University of California San Francisco
From its first class in 2008, with just seven students, to the current class of 36, the Institute for Global Health Sciences master’s program has given its students the breadth of tools and skills they need to succeed in global health careers.
UCSF’s Elizabeth Watkins wants to understand why there has been a recent uptick in the use of long-acting forms of contraception.
Model to treat HIV in rural East Africa led to 20% fewer HIV deaths, reduced the incidence of HIV and TB, and improved control of hypertension and diabetes.
New research demonstrates that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.
The Atlantic Philanthropies announced a new cohort of Atlantic Fellows, including Atlantic Fellows for Equity in Brain Health. The new fellows will be based at The Global Brain Health Institute at Trinity College Dublin and UCSF.
Clinicians and researchers at UCSF Benioff Children’s Hospital Oakland and UCSF are developing tools to combat negative health outcomes from toxic stress.
The eighth annual UCSF Sustainability Awards Ceremony honored more than 75 sustainability champions at UCSF.
UCSF scientists found a way to screen people’s blood for hundreds of chemicals at once, a method that will improve our ability to better assess chemical exposures in pregnant women.
A pilot clinical trial by CHORI researchers has found that targeted nutrient therapy can improve lung function in obese individuals with asthma, without requiring weight loss
UCSF scientists have used a high-throughput CRISPR-based technique to rapidly map the functions of nearly 500 genes in human cells, many of them never before studied in detail.
A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease.
Although CRISPR has made headlines as a powerful system for editing genes, it actually evolved as way for bacteria to defend themselves against infection by viruses.
UCSF researchers discovered fully formed gut and skin cells in the thymus, the organ responsible for training the T cells of the immune system not to attack the body’s own tissues.
School of Medicine Dean Talmadge E. King, Jr. announced the appointment of Bruce Ovbiagele as the new Associate Dean of the San Francisco VA Healthcare System.
Dignity Health and UCSF Health are collaborating to develop a state-of-the-art digital engagement platform that will provide information and access to patients when and where they need it.
About 250 UCSF staff, faculty, students and supporters came out on a cold and foggy morning in Golden Gate Park to raise funds in the annual AIDS Walk San Francisco event.
School of Medicine Dean Talmadge E. King Jr. announced the appointment of Kelley Meade as the new Interim Associate Dean of Clinical and Academic Affairs at UCSF Benioff Children’s Hospital Oakland,
Follow-up imaging for women with non-metastatic breast cancer varies widely across the country, according to a new study led by researchers at UCSF.
Study shows that a simplified intervention building on the hypertension treatment algorithm used in KP’s PHASE program can significantly improve rates of blood pressure control in the city’s safety net clinics.
In an achievement that has significant implications for research, medicine, and industry, UCSF scientists have genetically reprogrammed human immune cells without using viruses to insert DNA
UCSF School of Medicine is establishing a ‘branch campus’ at UCSF Fresno to lead a training program preparing students to address health needs of the region's diverse and underserved populations.
An examination of how the adoption of EHRs affected the quality of hospital care between 2008 and 2013 found that mortality rates fell as hospitals learned how to work with the technology.
Study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that about 17 percent of these cancers belong to a deadlier subtype of metastatic prostate cancer.
